Invention Grant
- Patent Title: Methods for treating psychosis associated with interferson-α therapy
-
Application No.: US10519008Application Date: 2003-07-02
-
Publication No.: US08476254B2Publication Date: 2013-07-02
- Inventor: Joseph K. Belanoff
- Applicant: Joseph K. Belanoff
- Applicant Address: US CA Menlo Park
- Assignee: Corcept Therapeutics, Inc.
- Current Assignee: Corcept Therapeutics, Inc.
- Current Assignee Address: US CA Menlo Park
- Agency: Kilpatrick Townsend & Stockton LLP
- International Application: PCT/US03/21245 WO 20030702
- International Announcement: WO2004/004653 WO 20040115
- Main IPC: A61K31/00
- IPC: A61K31/00 ; A61K31/56 ; A61K31/5685 ; A61K31/569 ; A61K31/70 ; A61K38/00 ; A61K38/21 ; A61P25/18
Abstract:
The present invention relates to the treatment of psychosis associated with interferon-α therapy by administering an amount of a glucocorticoid receptor antagonist effective to ameliorate the symptoms of psychosis in the patient, wherein the patient is not otherwise in need of treatment with a glucocorticoid receptor antagonist. The present invention further relates to kits for the treatment of Hepatitis C infection in a patient.
Public/Granted literature
- US20060063748A1 Methods for treating psychosis associated with interferson-alpha therapy Public/Granted day:2006-03-23
Information query
